Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Bladder Cancer Therapeutics and Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bladder Cancer Therapeutics and Diagnosticsmarket, defines the market attractiveness level of Bladder Cancer Therapeutics and Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bladder Cancer Therapeutics and Diagnostics industry, describes the types of Bladder Cancer Therapeutics and Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bladder Cancer Therapeutics and Diagnostics market and the development prospects and opportunities of Bladder Cancer Therapeutics and Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bladder Cancer Therapeutics and Diagnostics market in Chapter 13.
By Player:
Merck
GlaxoSmithKline
Sanofi
Pfizer
AstraZeneca
Novartis
Bristol-Myers Squibb
Celgene Corporation
Roche
Eli Lilly
By Type:
Chemotherapy
Immunotherapy
Radiation Therapy
Others
By End-User:
Hospitals
Oncology Treatment Centers
Ambulatory Surgery Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bladder Cancer Therapeutics and Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bladder Cancer Therapeutics and Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bladder Cancer Therapeutics and Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bladder Cancer Therapeutics and Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bladder Cancer Therapeutics and Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Bladder Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.2 United States Bladder Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.3 Europe Bladder Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.4 China Bladder Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.5 Japan Bladder Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.6 India Bladder Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.7 South Korea Bladder Cancer Therapeutics and Diagnostics Consumption (2017-2022)
8 Region and Country-wise Bladder Cancer Therapeutics and Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Bladder Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Bladder Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Bladder Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Bladder Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Bladder Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Bladder Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Bladder Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
9 Global Bladder Cancer Therapeutics and Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Treatment Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Surgery Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Bladder Cancer Therapeutics and Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Surgery Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Bladder Cancer Therapeutics and Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bladder Cancer Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bladder Cancer Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bladder Cancer Therapeutics and Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bladder Cancer Therapeutics and Diagnostics Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.8 Celgene Corporation
-
14.8.1 Celgene Corporation Company Details
-
14.8.2 Celgene Corporation Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Celgene Corporation Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.9 Roche
-
14.9.1 Roche Company Details
-
14.9.2 Roche Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Roche Bladder Cancer Therapeutics and Diagnostics Product and Service
-
14.10 Eli Lilly
-
14.10.1 Eli Lilly Company Details
-
14.10.2 Eli Lilly Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Eli Lilly Bladder Cancer Therapeutics and Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bladder Cancer Therapeutics and Diagnostics
-
Figure Bladder Cancer Therapeutics and Diagnostics Picture
-
Table Global Bladder Cancer Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bladder Cancer Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bladder Cancer Therapeutics and Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bladder Cancer Therapeutics and Diagnostics Consumption by Country (2017-2022)
-
Figure United States Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bladder Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Therapeutics and Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bladder Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Treatment Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgery Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgery Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bladder Cancer Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bladder Cancer Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Bladder Cancer Therapeutics and Diagnostics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Bladder Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Bladder Cancer Therapeutics and Diagnostics Product and Service
-
